Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review

INTRODUCTION: It is critical to select subsequent treatments for patients after the failure of trastuzumab therapy. Following the failure of standard trastuzumab therapy guidelines in the Chinese Society of Clinical Oncology, pyrotinib and capecitabine is a grade I recommended regimen for treating p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Ye, Liu, Xumei, Cai, Yi, Li, Wenyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815638/
https://www.ncbi.nlm.nih.gov/pubmed/36602979
http://dx.doi.org/10.1371/journal.pone.0279775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815638/
https://www.ncbi.nlm.nih.gov/pubmed/36602979
http://dx.doi.org/10.1371/journal.pone.0279775

Ejemplares similares